Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage

BACKGROUND: Patients with hematological malignancies often develop febrile neutropenia (FN) as a complication of cancer chemotherapy. Primary or secondary antifungal prophylaxis is recommended for patients with hematological malignancies to reduce the risk of invasive fungal infection (IFI). This st...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gedik, Habip, Şimşek, Funda, Yıldırmak, Taner, Kantürk, Arzu, Arıca, Deniz, Aydın, Demet, Demirel, Naciye, Yokuş, Osman
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
https://ncbi.nlm.nih.gov/pubmed/24855365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S59683
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg